Study Name Principal Investigator
(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study] McKie, Kathleen
(APOLLO) The APOL1 Long-term Kidney Transplantation Outcomes Network- APOLLO Study Gani, Imran
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(CONGA) COVID-19 Neurological and Molecular Prospective Cohort Study in Georgia Wang, Xiaoling
(Inspire Adhere) Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry Groves, Michael
A pilot study to assess acceptability of the ASICA intervention to support regular total-skin-self-examination by melanoma survivors in rural Georgia and South Carolina. Buchanan, Kendall
A011106; ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study Ghamande, Sharad
An Objective Tool to Aid Diagnosis of PTSD and Evaluate Treatment outcome Vazdarjanova, Almira
Antibodies in Amyotrophic Lateral Sclerosis Rivner, Michael
Assessment of Immune Cell function of kidney and kidney pancreas transplant recipients. A marker of strength of immunosuppression resulting from maintenance therapy after transplant: A Single Center Experience Gani, Imran
ATHN 10 – Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States Kutlar, Abdullah
D18-11141: Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage Cortes, Jorge
Defecation mechanisms and subtyping of constipation patients with Fecobionics Rao, Satish
Development of a patient centered primary and secondary prevention intervention for breast and ovarian cancer in African American women Vernon, Marlo
Developmental Gene Discovery Project: Mapping and Identifying New Genes in Uterine and Vaginal Development; Identifying New Genes Causing Birth Defects in Children Layman, Lawrence
Examining Media Frames and Biases in Coverage of Transgendered Athletes Hopkins, Ashley
GCC2020: Repurposing ibrutinib for chemo-immunotherapy in a phase 1b study of ibrutinib with indoximod plus metronomic cyclophosphamide and etoposide for pediatric patients with brain cancer Johnson, Theodore
Genetics of Delayed Puberty/ Genes Important in Puberty, Genetics of Infertility and Medical Illness Layman, Lawrence
Gilead GS-US-200-4334: A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination with Other Antiretroviral Agents in People Living with HIV Newman, Cheryl
GS-US-380-4580: A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of Two Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI) plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants Newman, Cheryl
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Vernon, Marlo
Improving Pregnancy Outcomes through Remote Monitoring and Rewards for Participation Vernon, Marlo
LAI116482: A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of HIV-1 virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects Newman, Cheryl
Maternal health- delayed antenatal care: Understanding barriers to care through the perspectives of new mothers who experienced delayed antenatal care in rural Georgia and rural Scotland Vernon, Marlo
Mechanisms Regulating Aquaporin 3 Expression in Keratinocytes and the Epidermis Bollag, Wendy
Needs Assessment for Remote Pregnancy and Postpartum Monitoring in Rural Georgia Vernon, Marlo
NMTRC 014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO) McDonough, Colleen
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease Kutlar, Abdullah
Screening for seroprevalence of Chagas disease in pediatric Latino population in Georgia Camelo, Ingrid
TESARO 4010-01-001: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Ghamande, Sharad
The Effects of KT-Tape on Running Economy and Muscle Activation. Craig-Jones, Andrew
Using a humanized mouse model to predict which potential living donor is immunologically the best match for a prospective living donor kidney transplant recipient. Mulloy, Laura
RESEARCH. INNOVATION. DISCOVERY.